Trial Profile
A Phase 3, Double-Blind, Randomized, Placebo Controlled Study of the Safety and Efficacy of AA4500 in the Treatment of Subjects With Dupuytrens Contracture Followed by an Open-Label Extension Phase
Status:
Not yet recruiting
Phase of Trial:
Phase III
Latest Information Update: 02 Jul 2019
Price :
$35
*
At a glance
- Drugs Collagenase clostridium histolyticum (Primary)
- Indications Dupuytren's contracture
- Focus Adverse reactions; Therapeutic Use
- Sponsors Auxilium Pharmaceuticals
- 11 Jul 2016 New trial record